Literature DB >> 11216526

Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi.

R C Marshall1, P Powers-Risius, B W Reutter, S E Taylor, H F VanBrocklin, R H Huesman, T F Budinger.   

Abstract

UNLABELLED: The goal of this investigation was to assess the accuracy of 7'-Z-[125I]iodorotenone (125I-iodorotenone) as a new deposited myocardial flow tracer and compare the results with those for 99mTc-sestamibi.
METHODS: The kinetics of these two flow tracers were evaluated in 25 isolated, erythrocyte- and albumin-perfused rabbit hearts over a flow range relevant to patients. The two flow tracers and a vascular reference tracer (131I-albumin) were introduced simultaneously as a compact bolus through a port just above the aortic cannula in the absence of tracer recirculation. Myocardial extraction, retention, washout, and uptake parameters were computed from the venous outflow curves using the multiple-indicator dilution technique and spectral analysis.
RESULTS: The extraction of 125I-iodorotenone was much higher than the extraction of 99mTc-sestamibi (0.84 +/- 0.05 vs. 0.48 +/- 0.10, respectively, P < 0.001). 125I-iodorotenone extraction was also less affected by flow than was 99mTc-sestamibi (P < 0.001). Net retention of 125I-iodorotenone was significantly greater than 99mTc-sestamibi net retention at 1 min (0.77 +/- 0.08 vs. 0.41 +/- 0.11, respectively, P < 0.001) and 26 min (0.46 +/- 0.13 vs. 0.27 +/- 0.11, respectively, P < 0.001) after tracer injection. Flow had less effect on 125I-iodorotenone net retention than on 99mTc-sestamibi net retention 1 min after tracer injection (P < 0.04). However, at 26 min, flow had an equivalent effect on the retention of both flow tracers (P < 0.4). The relationship between 125I-iodorotenone and 99mTc-sestamibi washout was complex and depended on elapsed time after isotope introduction and perfusion rate. Reflecting the favorable extraction and retention characteristics of 125I-iodorotenone, both its maximum myocardial uptake and its 26-min uptake were more closely related to flow than were those of 99mTc-sestamibi (P < 0.001 for both comparisons).
CONCLUSION: The extraction and retention of 125I-iodorotenone were greater than those of 99mTc-sestamibi, making 125I-iodorotenone the superior flow tracer in the isolated rabbit heart.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216526

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  Estimation of coronary flow reserve: can SPECT compete with other modalities?

Authors:  G T Gullberg; E V Di Bella; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

Review 2.  Dynamic single photon emission computed tomography--basic principles and cardiac applications.

Authors:  Grant T Gullberg; Bryan W Reutter; Arkadiusz Sitek; Jonathan S Maltz; Thomas F Budinger
Journal:  Phys Med Biol       Date:  2010-09-22       Impact factor: 3.609

3.  Novel SPECT perfusion imaging agents with improved myocardial or liver kinetics: experimental studies and the need for clinical evaluation.

Authors:  Laurent M Riou; Alexis Broisat
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

4.  Myocardial uptake of 7'-(Z)-[(123)I]iodorotenone during vasodilator stress in dogs with critical coronary stenoses.

Authors:  Alexis Broisat; Mirta Ruiz; Norman C Goodman; Stephen M Hanrahan; Bryan W Reutter; Kathleen M Brennan; Mustafa Janabi; Saul Schaefer; Denny D Watson; George A Beller; Henry F VanBrocklin; David K Glover
Journal:  Circ Cardiovasc Imaging       Date:  2011-09-14       Impact factor: 7.792

Review 5.  Emerging Tracers for Nuclear Cardiac PET Imaging.

Authors:  Dong-Yeon Kim; Sang-Geon Cho; Hee-Seung Bom
Journal:  Nucl Med Mol Imaging       Date:  2018-05-08

6.  Are SPECT measurements of myocardial blood flow and flow reserve ready for clinical use?

Authors:  Ernest V Garcia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12       Impact factor: 9.236

7.  Mitochondrial avid radioprobes. Preparation and evaluation of 7'(Z)-[125I]iodorotenone and 7'(Z)-[125I]iodorotenol.

Authors:  Henry F VanBrocklin; Stephen M Hanrahan; Joel D Enas; Erathodiyil Nandanan; James P O'Neil
Journal:  Nucl Med Biol       Date:  2006-11-28       Impact factor: 2.408

8.  Evaluation of (4-[18F]Fluorophenyl)triphenylphosphonium ion. A potential myocardial blood flow agent for PET.

Authors:  Timothy M Shoup; David R Elmaleh; Anna-Liisa Brownell; Aijun Zhu; J Luis Guerrero; Alan J Fischman
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

9.  Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent.

Authors:  Padmaja Yalamanchili; Eric Wexler; Megan Hayes; Ming Yu; Jody Bozek; Mikhail Kagan; Heike S Radeke; Michael Azure; Ajay Purohit; David S Casebier; Simon P Robinson
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

10.  BMS-747158-02: a novel PET myocardial perfusion imaging agent.

Authors:  Ming Yu; Mary T Guaraldi; Mahesh Mistry; Mikhail Kagan; Jennifer L McDonald; Kenneth Drew; Heike Radeke; Michael Azure; Ajay Purohit; David S Casebier; Simon P Robinson
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.